• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Sun Biologics in the West

anonymous

Guest
Sun in the west Ilumya sales is moving sales credit to the good ole boys. Just a bunch of liars and frauds. You have bad news heading to you very soon. They are bad people.